Galmed Pharmaceuticals (EOCN) EBITDA (2013 - 2024)
Galmed Pharmaceuticals' EBITDA was $1.84 million in FY2025, down 17.0% from $2.22 million in FY2024.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) EBITDA (2013 - 2024) Analysis & Trends
From FY2012 onward, Galmed Pharmaceuticals has reported EBITDA for 13 years.
- EBITDA has now declined for four consecutive years, with a five-year compound annual growth rate of -42.9% (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual EBITDA in data going back to FY2012.
- Per Business Quant data, EBITDA in earlier years was $2.22 million in FY2024 (-70.5%), $7.52 million in FY2023 (-57.5%), $17.69 million in FY2022 (-46.3%) and $32.92 million in FY2021 (+8.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 727,000.00 |
| Jun 30, 2023 | 582,000.00 |
| Mar 31, 2023 | -756,000.00 |
| Jun 30, 2022 | 295,000.00 |
| Mar 31, 2022 | -241,000.00 |
| Jun 30, 2020 | 5.83 Mn |
| Mar 31, 2020 | 6.47 Mn |
| Dec 31, 2019 | 8.29 Mn |
| Sep 30, 2019 | 4.52 Mn |
| Jun 30, 2019 | 4.71 Mn |
| Mar 31, 2019 | 4.05 Mn |
| Dec 31, 2018 | 4.33 Mn |
| Sep 30, 2018 | 1.32 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Mar 31, 2018 | 2.62 Mn |
| Dec 31, 2017 | 3.70 Mn |
| Sep 30, 2017 | 2.82 Mn |
| Jun 30, 2017 | 2.74 Mn |
| Mar 31, 2017 | 3.32 Mn |
| Dec 31, 2016 | 4.80 Mn |
API Access
Galmed Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();